The effect of the triterpenoid drugs carbenoxolone sodium (CBX) and cicloxolone sodium (CCX) on DNA and protein synthesis in uninfected and herpes simplex virus (HSV)-infected BHK-21 or Flow 2002 cells has been studied. No consistent effect of 500 BM-CBX or 300 ~tM-CCX on HSV DNA synthesis was identified. With 300 ~tM-CCX, some inhibition of cellular DNA synthesis was observed, but this was relatively slight. The restriction enzyme digest profiles of HSV DNA from drug-treated cells appeared normal. The synthesis of several HSV-specified polypeptides was much reduced by treatment with CBX or CCX and the transport of certain proteins between the nuclear and cytoplasmic compartments of infected cells was also affected. CBX or CCX treatment strongly inhibited post-translational glycosylation and sulphation of both host-and HSV-specified proteins, but the phosphorylation of only a few proteins appeared affected. The drugs induced quantitative changes in the synthesis of some BHK cell polypeptides, but these were not considered important. CCX treatment of Flow 2002 cells, however, induced the synthesis of several new polypeptides, some of which had the same apparent molecular weights as identified Flow 2002 cell stress proteins. When treated with concentrations greater than 50 IxM-CCX, the plasma membranes of both uninfected and HSV-infected cells became increasingly leaky. The SDS-PAGE polypeptide profile of purified virus particles made in BHK cells treated with 300 ~tM-CCX differed markedly from that synthesized under drug-free conditions. The greatly reduced amount of infectious virus made in cells treated with 300 ~tM-CCX was more thermolabile at 42 °C than virus produced in the absence of the drug. Our results indicate that the antiviral activity of the triterpenoid drugs is non-specific and operates by interfering with or changing the normal function of cell membranes so that cells, although retaining their viability, can no longer assemble the virus components efficiently into infectious particles. As a consequence, the population of virus particles made is of inferior quality. While we have no evidence that there is also a specific anti-HSV effect, this possibility cannot yet be ruled out.
INTRODUCTION Double-blind, placebo-controlled clinical trials of carbenoxolone sodium (CBX) and cicloxolone sodium (CCX) in man have suggested that these triterpenoid compounds have a beneficial effect on the course of herpes simplex virus (HSV) infection in vivo (Poswillo & Roberts, 1981 ; Csonka & Tyrrell, 1984; Partridge & Poswillo, 1984) . We have initiated a study of these compounds in vitro and have recently shown that CBX and CCX are potent inhibitors of HSV replication in tissue culture cells (Dargan & Subak-Sharpe, 1985) . The finding that CCX and CBX appear to inhibit HSV replication throughout the growth cycle suggests the operation of a novel mechanism of action. The anti-HSV activity is manifested by a dramatic increase in the virus particle/p.f.u, ratios; thus, growth in the presence of CCX or CBX leads to progeny (indicated by refractive index readings of the gradient fractions and by a peak of [35S]methionine-labelled material), Percoll was removed from the virus-containing fractions by centrifugation against a 60~ sucrose cushion in a Sorvall AH 650 rotor at 35 000 r.p.m, for 1 h. Sucrose was removed by dialysis against several changes of buffer (10 mM-Tris-HCl pH 7.5, 1 mM-EDTA). The virus preparations were then solubilized and prepared for SDS-PAGE.
RESULTS
The triterpenoid compounds can be cytotoxic, but the magnitude of their cytotoxic effect varied between cell lines. Cytotoxicity on Flow 2002 cells was negligible; however, the observed cytotoxic effect on BHK cells, without invalidating the qualitative conclusions drawn from experiments with these cells, could affect precise quantification (Dargan & Subak-Sharpe, 1985) .
Most of the experiments reported now were performed using both BHK and Flow 2002 cells although data obtained with only one or other of the cell systems are given. As HSV-I/BHK and HSV-2/BHK cell systems have been particularly well characterized, it seemed important to investigate their SDS-PAGE polypeptide profiles.
Effect of CBX and CCX on DNA synthesis
It was previously concluded from addition and removal experiments that the triterpenoid compounds exhibit antiviral activity throughout the HSV replication cycle (Dargan & SubakSharpe, 1985) . This does not point to a specific drug-induced block of virus DNA synthesis. Nevertheless, defects arising at any stage in HSV DNA synthesis, maturation or packaging, could account for our observation that the particle/p.f.u, ratios rise with increasing drug concentration. Consequently, it seemed appropriate to obtain a qualitative and quantitative assessment of viral DNA synthesized in drug-treated cells.
[3H]Thymidine incorporated into newly synthesized DNA between 3 and 20 h postadsorption was measured following extraction and banding of DNA in CsC1 gradients. The relative amounts of HSV DNA synthesized in infected BHK cells treated with 500 ~tM-CBX or 300 ~tM-CCX, listed as a percentage of that made by the drug-free controls are given in Table 1 .
There was considerable variation in the relative amounts of HSV DNA synthesized in the presence of the drugs, both between and within the three experiments. The source of this variation is not clear. We interpret the combined data as showing: first, no evidence of consistent drug-induced reduction of HSV DNA synthesis; second, no demonstrable effect upon mock-infected BHK cell DNA synthesis by 500 ~tM-CBX; third, about 50~ inhibition by 300 ~tM-CCX on DNA synthesis in mock-infected BHK cells. Thus, the antiviral effect of CBX andCCX differed from that of other commonly used anti-herpesvirus drugs, all of which act ultimately by blocking virus DNA synthesis (e.g. acyclovir, foscarnet, bromovinyldeoxyuridine, arabinosyl adenine, etc.).
Defective interfering (DI) HSV DNA is known to lead to a dramatic increase in the particle/p.f.u, ratios of virus stocks (Frenkel et al., 1976; Kaerner et al., 1979; Vlazny et al., 1982) . Such DI DNA is usually generated and accumulates following passage of virus at high multiplicity of infection. The restriction endonuclease digest patterns of DI HSV DNAs are readily identifiable even in the presence of normal HSV DNA because defective genomes consist of head-to-tail concatemers of only short sequences of the viral genome, which invariably contain one of the two origins of HSV DNA replication regions (Frenkel et al., 1976; Kaerner et al., 1979; Stow, 1982; Stow & McMonagle, 1983) . Conceivably, triterpenoid drug treatment favoured induction and/or accumulation of DI HSV DNA.
To assess the HSV DNA made in CCX-treated infected cells two techniques were used. First, nascent DNA was labelled with 32P i and prepared for restriction endonuclease analysis by the method of Lonsdale (1979) . Second, unlabelled BgllI-digested HSV DNA from CCX-treated infected cells was blotted onto nitrocellulose sheets (Southern, 1975) and hybridized with a 32p-labelled nick-translated HSV DNA probe.
Little information could be gained from the former technique because incorporation of 32p i into DNA decreased rapidly with increasing CCX concentrations; when these exceeded 50 IxM, labelling became inadequate for autoradiography.
This unexpected, but consistent, finding could have arisen in three ways: a great reduction of DNA synthesis in CCX-treated cells, which directly conflicts with the data given in Table 1 ; or impairment of the uptake of externally supplied 32p i by the cell or nucleus, due to some modification affecting either the plasma or nuclear membranes; or by reduction of orthophosphate incorporation into nucleotides. ~ To circumvent these possibilities, Southern blot analysis (as above) was performed with unlabelled DNA extracted from HSV-1-or HSV-2- (Fig. 1 a, b) Table 1 , and second that there was no build-up of DI DNA, since the BgllI digest profiles of HSV-1 and HSV-2 DNA appeared normal. We do not feel it would be justified to attempt quantitative interpretation of band intensity differences of these Southern blots. Further experiments are in progress to define further the effects of CCX and CBX on viral DNA synthesis, maturation and packaging. The infectious virus yield controls for the experiment shown in Fig. 1 demonstrated a 3 .1 log10 reduction in yield from HSV-l-infected Flow 2002 cells treated with 300 ~tM-CCX and a 4.6 log10 reduction in yield from similarly treated BHK cells infected with HSV-2.
The data suggest that the triterpenoid compounds did not directly affect HSV DNA synthesis in infected cells, although in some experiments the amounts of virus DNA made were reduced. In normal HSV infection only about 20 ~o of the virus DNA is eventually packaged (Wilkie, 1973) . Thus, it seems unlikely that the reduction in virus DNA synthesis observed in some experiments employing CCX have contributed materially to the accompanying massive drug-induced To support the thesis that the triterpenoid compounds' mode of action differs from that of the commonly used anti-herpesvirus drugs that operate in this way, three HSV mutants were studied: HSV-1 (17) TK 1301 and 1302, which both have the TK gene deleted (Sanders et al., 1982) , and HSV-2 52 ACG r CC 2321 which is resistant to both ACG and PAA through at least two mutations in the D N A polymerase gene (Crumpacker et al., 1980) . Sensitivity of such mutants to triterpenoid drug treatment would imply a different mode of action. Fig. 2 gives the results of a 24 h virus dose-response experiment performed using ACG r 2321 (Fig. 2a 
Drug effect on polypeptide synthesis
The loss of quality when virus was grown in the presence of triterpenoid drugs could be due to changes in the synthesis, processing or assembly of virus-specified polypeptides. The effect of CBX and CCX on host cells-and HSV-specific protein synthesis was investigated by longlabelling and pulse-chase experiments.
BHK or Flow 2002 cells were infected at a m.o.i, of 20 p.f.u./cell with either HSV-1 (17 syn ÷) or HSV-2 (HG52), adsorbed for 1 h at 37 °C, washed twice with PBS, and then overlaid with E1/5metC2 or E1/5metFC2 containing CBX (500 gM in long label and 50, 100, 200, 500 or 1000 gM in pulse-chase experiments) or CCX (50, 100, 200 or 300 ].tM in both long label and pulse-chase experiments).
Long label
The gel profile of polypeptides from mock-infected BHK cells appeared not to be qualitatively altered by treatment with 500 ~tM-CBX (Fig. 3) or 300 ~tM-CCX (data not shown), but changes in the intensities of several protein bands were noted in both the nuclear and cytoplasmic fractions (Fig. 3 ). These were not consistently observed except for the two indicated bands in the cytoplasmic fraction.
In the nuclear fraction of drug-treated infected BHK cells, two immediate-early (IE) HSV polypeptides (Vmw 175 and ll0K of HSV-1 and Vmw 182 and l18K of HSV-2) known to be involved in transcription control (Preston, 1979; Everett, 1984) were substantially reduced. Several additional HSV-1 polypeptides (Vmw 136', 122, 82/81, 65/64, 39/38, 37/36, 32, 30 and 21K) and HS¥-2 polypeptides (Vmw 157, 134/132, 90, 66/65, 57', 38, 25 and 20K) strongly diminished in intensity; in contrast, certain HSV-1 (Vmw 87/85, 67 and 28K) and HSV-2 (Vmw 87 and 29K) polypeptides were increased. Few drug-related differences were detected in the infected B H K cell cytoplasmic fractions except that HSV-1 polypeptides Vmw 145, 87/85 and 28K and the HSV-2 Vmw 144K polypeptide were reduced (Fig. 3) . Essentially the same results were obtained from S D S -P A G E analysis of HSV-1-and HSV-2-(not shown) infected Flow 2002 ceils treated with up to 300 p.M-CCX (Dargan & Subak-Sharpe, 1986) . Pulse-chase In mock-infected BHK cell cytoplasmic fractions five protein bands diminished and five increased in intensity with increasing CBX concentration (Fig. 4a) . No consistent protein pattern changes were detected in the nuclear fraction of mock-infected BHK cells. Interestingly, less label was incorporated into the nuclear proteins of mock-infected, but not those of infected cells, with 500 ktM-or 1 mM-CBX.
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Seven major polypeptide bands and several minor ones, induced by CCX treatment, were apparent in the nuclear and cytoplasmic extracts of mock-infected Flow 2002 cells treated with 50, 100, 200 or 300 ~tM-CCX (Fig. 4c, d ). Three of these bands (mol. wt. 83K, 70K and 63K) migrated as do identified Flow 2002 cell stress proteins (E. Notarianni, personal communication), but they have not yet been further characterized.
Analysis of the nuclear (Fig. 4b) and cytoplasmic ( Fig. 4a) proteins of infected BHK cells revealed at least four types of response to increasing CBX concentrations. (i) Polypeptides decreased in both the nuclear and cytoplasmic fractions (Vmw 273, 175, 122, 37 and 21K) . (ii) Polypeptides increased in both the nuclear and cytoplasmic fractions (Vmw 117 and 51K). (iii) Polypeptides decreased in the cytoplasmic but increased in the nuclear fraction (Vmw 145, 87/85, 67, 65/64, 43 and 28K) and (iv) polypeptides which appeared quantitatively unchanged in the nuclear but in decreased amounts in the cytoplasmic fraction (Vmw 155 and 30K).
Similar experiments done with HSV-2 at various CCX concentrations both in BHK or Flow 2002 cell lines yielded essentially similar results.
These data show that triterpenoid drug treatment had at least three different effects upon HSV-directed protein synthesis. First, the levels of some virus proteins, including IE proteins, were depressed both in the nucleus and the cytoplasm; second, some virus proteins were increased in both compartments; third, the normal distribution of certain virus proteins between the nucleus and cytoplasm was disturbed. 
Effect on post-translational processing of proteins

Glycosylation
At least six major glycosylated proteins (gB, gC, gD, gE, gG and gH) have been identified in HSV-infected cell extracts (Spear, 1976; Marsden et al., 1978 Marsden et al., , 1984 Eberle & Courtney, 1980; Palfreyman et al., 1983; Roizman et al., 1984; Buckmaster et al., 1984; Frame et al., 1986) .
The glycosylated proteins in extracts of mock-infected and HSV-l-infected Flow 2002 cells grown in the presence of various concentrations of CCX are shown in Fig. 5 . In these gels, gC was not resolved from gB, and gG and gH were not detected.
[3H]Mannose incorporation into host or virus glycoproteins was radically reduced in Flow 2002 cells treated with 50 ~tM-CCX and essentially abolished by 300 ~tM-CCX. Glycoprotein E does not label strongly with [3H]mannose and cannot usually be resolved with this label. In the presence of 50 ~tM-CCX only minimally glycosylated precursor forms were detected, and even this was virtually abolished at the higher concentrations (200 and 300 ~tM) of the drug. Very similar results have been obtained with BHK cells infected with HSV-1 or HSV-2 and treated with increasing concentrations of CBX: incorporation of [3H]mannose into gB, gC, gD and gE was strongly inhibited by 100 ~tM-CBX and was abolished by 500 ~tM-CBX (Dargan & Subak-Sharpe, 1986 ).
Sulphation
All the major HSV glycoproteins, with the possible exception of HSV-2 gG, also label with sulphate (Hope et al., 1982; Hope & Marsden, 1983) . In BHK cells gE is the most strongly sulphated, but in infected profile (Fig. 6 ). This manifested as an increase in the intensity of an apparent precursor band (see also Fig. 5 ). Fig. 6 shows that CCX in HSV-l-infected Flow 2002 cells had a strong concentration-dependent inhibitory effect on the sulphation of all four major glycoproteins, gB, gC, gD and gE. Essentially the same results were obtained in BHK cells infected with HSV-1 or HSV-2 and treated with CBX (Dargan & Subak-Sharpe, 1986 ). In the presence of 500 ktM-CBX, incorporation of 35SO4 into HSV-1 gB and gC was almost abolished while that into gD and gE was greatly reduced in both the nuclear and cytoplasmic compartments. This effect on gE was also observed with HSV-2, although gB, gC and gD barely label with 35SO 4 in HSV-2 infections (Hope et al., 1982) .
On: Wed, 02 Jan 2019 21:52:03 Symons & Parke (1980) investigated the stability of lysosomal m e m b r a n e s a n d artificial phosphatidylcholine/cholesterol liposomes and observed a concentration-dependent biphasic effect of CBX on permeability; at the pharmacological levels administered in the treatment of peptic ulcers they found significant stabilization of the membanes, but at higher doses (100 ~M to 1 mM) these became increasingly leaky.
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Effect of CCX on the secretion of proteins
The present study shows that increasing the CCX concentration consistently raised the percentage of total labelled protein secreted from mock-infected and HSV-l-infected BHK and Flow 2002 cells (Fig. 8) . At high CCX concentrations more protein was secreted from infected than from mock-infected cells; without drug, HSV infection consistently reduced protein secretion. Very similar results were obtained with CBX-treated cells and when cells were infected with HSV-2. Concentrations of 1 and 5 ~LM-CBX were found to stabilize the cell membranes (data not shown) These findings are entirely consistent with those of Symons & Parke (1980) . As greater than 949/oo of cells survive 24 h incubation in the presence of 300 p.M-CCX (Dargan & Subak-Sharpe, 1985) , it seems unlikely that the secretion data can be explained by more cells lysing with increasing CCX concentration.
We are currently analysing the CCX effect on polypeptide species, either secreted from mockinfected and HSV-infected cells, or remaining cell-associated. It is already established that the increase in the total protein excreted from CCX-treated cells reflects extensive quantitative and qualitative changes in the normal pattern.
Protein content of virus purified from CCX-treated cells
We have demonstrated drug-induced disturbances in HSV directed protein synthesis, nuclear/cytoplasmic transport of proteins and post-translational processing of proteins. To determine the effect this had on the polypeptide constitution of the virus particles made in the presence of the drug, HSV particles were purified from infected BHK cells by Percoll density gradient separation (Svennerholm et al., 1980) and their protein content was examined by SDS-PAGE.
Many differences in protein profile were evident between the cell-associated (CAV) and cellreleased virus (RV) (Fig. 9) . Proteins Vmw 273, 136', 129, 122 (gB), 110 (gC), 100, 87/85, 82/81, 67, 65/64, 57 (gD), 39, 37', 32, 23, 21, 19, 16"5, 14 , 12"5 and IlK were reduced in intensity in the CAV preparation from 300 ~tM-CCX-treated cells; a single band, Vmw 43K, exhibited greater intensity. In the RV preparations from CCX-treated cells, Vmw 129,117 (pgB), 110 (gC), 87/85, 82/81, 67, 65/64, 57 (gD), 23, 19, 16"5, 14 and 12-5K had reduced intensity. Vmw 122 (gB) and 21 K, while lower in intensity than their drug-free counterparts, were of greater intensity than the corresponding proteins present in the CAV preparations; Vmw 273, 136', 90, 78, 51 (pgD) , 43 and 39/38K showed increased intensity. Thus, the virus particles contained an abnormal set of structural proteins. This is consistent with the observed drug-induced effects on HSV-directed protein synthesis, transport and processing.
Most (if not all) of the CAV proteins affected were in the tegument (e.g. Vmw 273 and 65/64K) and envelope proteins (e.g. Vmw 122, 110, 57, 12"5 and 11K) . It is interesting that fewer proteins were under-represented in the virus released from CCX-treated cells than in the CAV fraction, but note that the envelope constituents remained under-represented although the level of gB was only slightly depressed. These observations suggest that acquisition of tegument proteins was a prerequisite for release of virus from cells. Conclusions regarding the envelopment state of virus released from CCX-treated cells cannot be drawn from these data, but envelopes, if present, could not have possessed the normal complement of certain proteins (e.g. Vmw 122, 110, 57 and 12.5K). The ratio of cell-released to cell-associated virus particles is known not to be substantially altered by triterpenoid drug treatment (Dargan & Subak-Sharpe, 1985) .
The over-representation of Vmw 43K in both the CAV and RV fractions of CCX-treated cells is interesting since such a protein accumulates in the nucleus of CBX-or CCX-treated HSVinfected cells (Fig. 4) . It is tempting to speculate that this was not the 43K TK protein, which is not present in purified virions (L. Haarr, personal communication), but rather represented overproduction of the 43K HSV core protein (Gibson & Roizman, 1972) . Dargan & Subak-Sharpe (1985) reduces the infectious virus yield 1000-to 100000-fold, but with HSV-1 a small amount was still made, even at 300 ~tu-CCX. Such infectious HSV-1 virus made in cells treated with various concentrations of CCX, was employed in thermostability studies. At 24 h post-adsorption, the yield from BHK cells infected with HSV-1 (17 syn ÷) at a m.o.i. of 5 p.f.u./cell and treated with CCX was separated into CAV and RV components. For logistic reasons only the virus in the CAV preparation could be studied. Protein in each sample was estimated (Lowry et al., 1951) and where necessary equilibrated by addition of BSA. The percentages of virus surviving treatment are shown by Fig. 10 .
Thermostability of infectious virus produced in CCX-treated cells
Virus grown under drug-free conditions resisted inactivation at 42 °C for up to 45 min. Virus grown in cells treated with 100 btM-CCX began to drop in titre after 30 min incubation whereas inactivation of virus fom cells treated with 200 btM-CCX became detectable after only 15 min. There was a dramatic progressive loss of infectivity in the virus from cells treated with 300 p.u-CCX, only 5 ~ surviving 60 min incubation at 42°C.
The infectious virus synthesized in the presence of increasing concentrations of CCX was progressively more labile. Thermolability thus signifies a further consequence of the abnormal polypeptide composition of virus produced in the presence of CCX which generated poor quality virus particles. However, as this same virus proved not to be differentially affected by incubation for 2 h at 37 °C with 50 Ixg/ml DNase I, its abnormal polypeptide composition did not permit effective penetration by the enzyme (data not shown).
DISCUSSION
Several biochemical consequences of triterpenoid drug treatment of mock-infected and HSVinfected cells have been studied, to gain some understanding of the antiviral activity of these compounds. Unlike most anti-HSV drugs in clinical use, the triterpenoids do not act by specifically inhibiting virus DNA synthesis (Table 1) . This is consistent with the earlier conclusions that they act throughout the entire virus replication cycle (Dargan & Subak-Sharpe, 1985) . The variation in the amount of viral DNA made in the presence of the drug both between and within experiments (Table 1) may be due to indirect effects upon protein synthesis, transport or processing. Analyses of the restriction endonuclease patterns of virus DNA from infected cells treated with CCX eliminated the possibility that DI DNA might have accounted for, or contributed to, the observation that HSV particle/p.f.u, ratios increase dramatically with increasing drug concentration (Dargan & Subak-Sharpe, 1985) . Encapsidation of virus DNA is currently under investigation, as it is possible that the high particle/p.f.u, ratio is caused by failure of packaging.
Protein synthesis in HSV-infected drug-treated cells was examined under long labelling (3 to 24 h) and pulse--chase conditions (5 to 7.5 h, chased until 24 h) and the nuclear and cytoplasmic fractions of cells were analysed. Under long labelling conditions several HSV-1 polypeptides were under-represented with increasing drug concentration, in one or other compartment (Vmw 175, 136', 122, 110, 82/81, 65/64, 39/38, 37, 36, 32 and 21K in the nucleus, and Vmw 145, 87/85 and 28K in the cytoplasm). Some clues concerning the functional importance of individual infected cell polypeptide bands can be derived from our previous study of the poiypeptide profiles obtained under long labelling conditions for non-ts revertants of HSV-1 ts mutants (Dargan & Subak-Sharpe, 1984) . When examining the profiles of incomplete revertants it had been noted that some polypeptide bands always regained wild-type intensity while others were frequently under-represented. Thus, two classes of infected cell protein could be identified: those required in wild-type amounts for virus growth and those which are not. Considering the proteins under-represented in HSV-l-infected drug-treated cells, drug-free (wild-type) levels of Vmw 175, 145, 65/64, 39, 30, 28 and 21K can be inferred to be essential for virus growth while drug-free (wild-type) levels of Vmw 136', 122, 82/81 and 38K are not.
The pulse-chase experiments revealed that the triterpenoid compounds interfere with the normal transport of proteins across the nuclear membrane. Four classes of infected cell polypeptide were identified on the basis of the relative amounts of individual polypeptides present in the nuclear or cytoplasmic fractions compared to the drug-free controls.
The quantitative and qualitative changes in the protein profiles of uninfected Flow 2002 cells, but not BHK cells, at relatively low drug concentrations (50 IxM-CCX) appear to involve stress proteins induced by CCX treatment. If correct, then this could account for the observed higher CCX tolerance of Flow 2002 cells compared with BHK cells (Dargan & Subak-Sharpe, 1985) .
Drug treatment inhibited the post-translational modification of both host-and virus-specified proteins. At 300 p.M, CCX virtually abolished glycosylation, and strongly inhibited sulphation; the effect on phosphorylation was less pronounced although some reduction in the levels of 3zPi incorporated into Vmw 82 and 65'K was consistently observed. In contrast, several host phosphoprotein bands increased in intensity with increasing CCX concentration. This points to differences in protein kinase activities in uninfected and HSV-infected cells. The drugs have a biphasic effect on glycosylation. The lowest concentration of CCX used (50 ~tM) appears to abolish most of the processing of HSV glycoproteins, but allows some glycosylation of the apparent precursor forms. At higher concentrations (> 100 ~tM) even glycosylation of the precursor forms is virtually, though not completely, abolished. This suggests a possible differential effect of the triterpenoid compounds on membranes of the endoplasmic reticulum [where the first addition of the N-linked core sugars occurs (Pizer et al., 1980; Peake et al., 1982) ] and in the membrane of the Golgi apparatus [where further sugar additions are made to the maturing N-linked oligosaccharides and also where O-linked oligosaccharides are added to the glycoprotein (Johnson & Spear, 1982 ]. Fifty ~tM-CCX only lowers the HSV yield by 70~ or less but at higher concentrations the yield is reduced by several loglo units; this implies that the triterpenoid effect on O-linked glycosylation and/or complete maturation of N-linked glycosylation is of lesser consequence for virus particle infectivity than the effect on addition of the N-linked core sugars to the precursor glycoprotein.
Our observations are entirely consistent with those of Pizer et al. (1980) , who observed a reduction in infectious virus yield from cells treated with tunicamycin (this compound blocks the initial N-linked core sugar addition), and those of Johnson & Spear (1982) who observed infectious enveloped virus bearing immature envelope glycoproteins in cells treated with monensin (this ionophore prevents the normal function of the Golgi apparatus). The effect on glycosylation of HSV proteins must make a significant contribution to the overall observed antiviral activity of the triterpenoid compounds; however, the other differential effects on virusspecific and cell proteins demand that this inference be further tested.
Sulphation only becomes strongly affected at concentrations greater than 100 ~tM-CCX, which suggests that it is associated with precursor glycoproteins having only N-linked core sugars. That triterpenoid drug treatment affects protein synthesis, transport and processing, suggests that the antiviral action of the drugs derives from their interference with, or change of, normal cell membrane functions. As these compounds are highly lipophilic and consequently have high affinity for biological membranes (Johnston et al., 1974) it is hardly surprising that they perturb some membrane functions.
At least three drug effects on the plasma membrane have been identified. First, pretreatment of cells with the drugs inhibits virus adsorption (Dargan & Subak-Sharpe, 1985) , second, both uninfected and HSV-infectcd cells become progressively more leaky when treated with CCX or CBX concentrations above 50 ~tM, and third concentrations below 10 }~M-CBX stabilize the membranes. The findings are consistent with the report of Symons & Parke (1980) that CBX has a concentration-independent, biphasic effect on stability of both isolated lysosomal membranes and artificial phosphatidylcholine/cholesterol liposomal membranes. The biphasic effect may also explain the apparent conflict between the reported increase in glycosylation and mucopolysaccharide synthesis when CBX is employed in the treatment of peptic ulcers (Klein et al., 1974; Johnston et al., 1974) and the marked reduction in glycosylation which we have observed with 100 p.M-CBX (Dargan & Subak-Sharpe, 1986) .
The drug-induced disturbances in HSV-specific protein synthesis, transport and processing culminate in the production of low quality virus particles, having many tegument and envelope polypeptides either under-represented or absent. The small quantity of cell-associated infectious HSV-1 made in the presence of the drugs exhibited increased thermolability; thus, even the infectious virus grown in drug-treated cells is of inferior quality to standard virus. This effect on virus quality may contribute to the reported clinical benefit obtained by Poswillo & Roberts (1981) and Csonka & Tyrrell (1984) .
Although it seems unlikely that the drugs are also endowed with a specific anti-HSV effect, this possibility is not yet ruled out. So far, triterpenoid drug-resistant HSV mutants have not been isolated.
In conclusion, it is proposed that the broad range of antiviral activity exerted by triterpenoid drugs operates through disturbances of the normal function of host cell membranes. The drug effect is non-specific and affects protein synthesis, transport and processing. With HSV this leads to a reduction in the number of virus particles synthesized and in a dramatic lowering in the quality of that virus which is made (Dargan & Subak-Sharpe, 1985) . The many anomalies in structural protein content of the virus particles which are assembled render most virions noninfectious, generating the observed high particle/p.f.u, ratio (Dargan & Subak-Sharpe, 1985) . Even the few infectious virus particles produced display inferior quality; the particle/p.f.u, ratio of cell-released virus preparations invariably exceeds that of the cell-associated virus (Dargan & Subak-Sharpe, 1985) .
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